(Q36433293)

14 August 2017

0 references

Combined Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplantation in Mucopolysacharidosis Type VI. (English)

1 reference

enzyme replacement therapy

14 August 2017

0 references

author name string

D Sillence

1

1 reference

14 August 2017

K Waters

2

1 reference

14 August 2017

S Donaldson

3

1 reference

14 August 2017

P J Shaw

4

1 reference

14 August 2017

C Ellaway

5

1 reference

14 August 2017

6 September 2011

1 reference

Journal of Inherited Metabolic Disorders Reports

14 August 2017

1 reference

14 August 2017

2

1 reference

14 August 2017

103-106

1 reference

Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509847

Mucopolysaccharidosis VI.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509847

Mucopolysaccharidosis I: management and treatment guidelines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509847

Management guidelines for mucopolysaccharidosis VI.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509847

Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509847

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509847

Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509847

Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509847

Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3509847

Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patients

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23430861

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Combined enzyme replacement and haematopoietic stem cell transplantation in Hurler syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23430861

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/8904_2011_56

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

23430861

1 reference